Stonebridge Capital Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-100
| Closed | -$5.7K | – | 659 |
|
|
2023
Q3 | $5.7K | Hold |
100
| – | – | ﹤0.01% | 689 |
|
|
2023
Q2 | $6.13K | Hold |
100
| – | – | ﹤0.01% | 687 |
|
|
2023
Q1 | $6.28K | Hold |
100
| – | – | ﹤0.01% | 677 |
|
|
2022
Q4 | $6.35K | Hold |
100
| – | – | ﹤0.01% | 669 |
|
|
2022
Q3 | $6K | Hold |
100
| – | – | ﹤0.01% | 660 |
|
|
2022
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 690 |
|
|
2022
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 754 |
|
|
2021
Q4 | $7K | Hold |
100
| – | – | ﹤0.01% | 697 |
|
|
2021
Q3 | $7K | Sell |
100
-100
| -50% | -$7K | ﹤0.01% | 677 |
|
|
2021
Q2 | $15K | Buy |
200
+100
| +100% | +$7.5K | ﹤0.01% | 672 |
|
|
2021
Q1 | $7K | Buy |
+100
| New | +$7K | ﹤0.01% | 683 |
|
|
2020
Q3 | – | Sell |
-100
| Closed | -$6K | – | 559 |
|
|
2020
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 553 |
|
|
2020
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 562 |
|
|
2019
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 626 |
|
|
2019
Q3 | $5K | Hold |
100
| – | – | ﹤0.01% | 625 |
|
|
2019
Q2 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 675 |
|